BOULDER — Oncology pharmaceuticals producer OnKure Inc. has hired Roberta (Robbie) Alton as its new vice president of clinical development.
Alton was most recently the head of clinical operations at Denovo Biopharma LLC.
“I am honored to join OnKure and its team of esteemed industry veterans who have a strong history of successful drug discovery and development,” she said in a prepared statement. “OnKure’s proven structure-based drug design approach has great promise, and I look forward to utilizing my clinical operations background to support the clinical advancement of its pipeline of oncology precision medicines.”
OnKure CEO Tony Piscopio said, “Robbie is joining at a critical time in our clinical journey, and we look forward to her immediate contributions as we prepare to initiate the Phase 2 portion” of the company’s skin cancer drug candidate trial.